YOUR BUSINESS AUTHORITY
Springfield, MO
The U.S. Food and Drug Administration yesterday approved the first new depression medication since the 1980s.
Johnson & Johnson's new drug Spravato is the brand name for esketamine, a nasal spray designed to treat severe forms of depression.
It contains the chemical mirror image of ketamine, which is used for its psychedelic effects.
Read more from Business Insider.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
Thanksgiving staple recalled at Costco
HBA of Greater Springfield executive officer to retire
Warren Buffett donates $5.5B worth of Berkshire Hathaway shares
Transportation officials discuss $471M Forward 44 initiative
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.
Ozarks Farm Stop remains open after car crashes into building